Atorvastatin → new-onset diabetes — Null result

Drug: atorvastatin · AE: new-onset diabetes · vs placebo

Caliper validation of the submitted claim (drug=atorvastatin, AE=new-onset diabetes, comparator=placebo). BELOW_DEDUP_THRESHOLD — only 0 unique cases after dedup; insufficient signal density

Disproportionality

• PRR: 2.408154424733363 (95% CI 0.15–38.67)
• Yates χ²: 0.4167273958483354
• Cases (case-drug + AE): n = 0
• Verdict: BELOW_DEDUP_THRESHOLD — only 0 unique cases after dedup; insufficient signal density

Top reactions in cohort

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.